Karolinska Development AB

Karolinska Development AB is a venture capital firm specializing in investments in growth capital, seed-stage, and early-stage companies within the life sciences sector. It focuses on pharmaceutical research and development, medical innovations, healthcare technology, gene research, drug delivery technologies, biotechnology, and life science tools and services. Primarily targeting the Nordic region, including Sweden, Iceland, Norway, Finland, and Denmark, the firm prefers to act as the lead investor in its portfolio companies while also considering co-investments, aiming to support up to five projects annually. Founded in 2003 and headquartered in Stockholm, Sweden, Karolinska Development AB plays a pivotal role in bridging innovative medical breakthroughs to the market by providing strategic funding and expertise to promising healthcare ventures. With a lean team of eight employees led by CEO Dr. Viktor Drvota, it operates in the biotechnology industry under the broader healthcare sector, fostering advancements that address unmet medical needs.